Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1897 1
1901 1
1907 1
1912 2
1913 2
1915 2
1922 2
1943 1
1944 1
1945 1
1946 1
1948 1
1949 3
1952 1
1953 2
1954 1
1959 1
1960 1
1962 1
1963 1
1965 2
1966 1
1968 1
1970 1
1971 2
1972 1
1973 2
1974 2
1975 3
1976 5
1977 1
1978 1
1979 3
1980 1
1981 1
1983 1
1985 14
1986 1
1987 5
1988 2
1989 4
1990 5
1991 4
1992 6
1993 8
1994 8
1995 4
1996 4
1997 2
1998 8
1999 4
2000 6
2001 9
2002 7
2003 10
2004 13
2005 9
2006 22
2007 22
2008 23
2009 19
2010 20
2011 35
2012 25
2013 24
2014 21
2015 27
2016 26
2017 31
2018 31
2019 33
2020 35
2021 23
Text availability
Article attribute
Article type
Publication date

Search Results

554 results
Results by year
Filters applied: . Clear all
Page 1
Trial of Dexamethasone for Chronic Subdural Hematoma.
Hutchinson PJ, Edlmann E, Bulters D, Zolnourian A, Holton P, Suttner N, Agyemang K, Thomson S, Anderson IA, Al-Tamimi YZ, Henderson D, Whitfield PC, Gherle M, Brennan PM, Allison A, Thelin EP, Tarantino S, Pantaleo B, Caldwell K, Davis-Wilkie C, Mee H, Warburton EA, Barton G, Chari A, Marcus HJ, King AT, Belli A, Myint PK, Wilkinson I, Santarius T, Turner C, Bond S, Kolias AG; British Neurosurgical Trainee Research Collaborative; Dex-CSDH Trial Collaborators. Hutchinson PJ, et al. Among authors: barton g. N Engl J Med. 2020 Dec 31;383(27):2616-2627. doi: 10.1056/NEJMoa2020473. Epub 2020 Dec 16. N Engl J Med. 2020. PMID: 33326713 Clinical Trial.
MyD88: a central player in innate immune signaling.
Deguine J, Barton GM. Deguine J, et al. Among authors: barton gm. F1000Prime Rep. 2014 Nov 4;6:97. doi: 10.12703/P6-97. eCollection 2014. F1000Prime Rep. 2014. PMID: 25580251 Free PMC article. Review.
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA, Baldwin DS, Drummond LM, Wyatt S, Hanson J, Gopi S, Kaur S, Reid J, Marwah V, Sachdev RA, Pampaloni I, Shahper S, Varlakova Y, Mpavaenda D, Manson C, O'Leary C, Irvine K, Monji-Patel D, Shodunke A, Dyer T, Dymond A, Barton G, Wellsted D. Fineberg NA, et al. Among authors: barton g. Int Clin Psychopharmacol. 2018 Nov;33(6):334-348. doi: 10.1097/YIC.0000000000000237. Int Clin Psychopharmacol. 2018. PMID: 30113928 Free PMC article. Clinical Trial.
CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.
Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. Zanoni I, et al. Among authors: barton gm. Cell. 2011 Nov 11;147(4):868-80. doi: 10.1016/j.cell.2011.09.051. Cell. 2011. PMID: 22078883 Free PMC article.
554 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page